Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.

Construction is expected to start in the second half of 2026, with commercialization in 2028, says Unibio CEO David Henstrom.

In the evolutionary history of life, the ability of a cell to separate its inner world from the external environment was an ...

Scientists from the National University of Singapore (NUS) have developed a biochemical technique that captures fleeting ...

Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of ...

In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji, MD, PhD, and Christina Chang, PhD, will discuss the current landscape of imaging- and next-generation sequencing-based ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

A new study shows that improving your cardiovascular endurance changes your neural chemistry. Fitter individuals release ...